Abortive replication and reactivation in vitro respiratory syncytial virus (RSV) infection in palivizumab-treated HeLa cells Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016
Enhanced severity of virus associated asthma exacerbations is not associated with delayed viral clearance and increased viral load Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005
Prolonged viral RNA shedding in patients with COVID-19 infection Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021
Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016 Year: 2017
Effects of respiratory syncytial virus and adenovirus infection in cytokine expression and nuclear factor-κB activation human bronchial epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 192s Year: 2006
Impaired viral clearance after influenza infection in IDO transgenic mice Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005
Defective endogenous antiviral mediator production in response to viral infection Source: International Congress 2015 – Resolving inflammation Year: 2015
High-capacity adenoviral vectors for gene transfer: reduced toxicity and reduced cell-cycle dysregulation Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020
Reduced chemokine responses in human neonatal cells upon infection with RSV. Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017
Fas-deficiency is deleterious in a murine model of RSV infection Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009
RSV infection induces MDC production in respiratory epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 482s Year: 2004
Lymphocytes mediate the anti-apoptotic effect of respiratory syncytial virus on human neutrophils Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity Year: 2007
Non-viral and viral gene transfer in ex vivo and in vivo lung models Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009
Potential inhibitors of respiratory syncytial virus (RSV) selected from a phage displayed random peptide library Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002
LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells Source: International Congress 2016 – Translational research in respiratory infections Year: 2016
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Source: Eur Respir J 2011; 38: 401-408 Year: 2011
Inhibition of Pim1 kinase reduces viral replication in primary bronchial epithelial cells Source: Eur Respir J 2015; 45: 1745-1748 Year: 2015
Comparison of the downregulation of AQP5 gene expression by synthetic siRNA and vector-based shRNA Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
Persistent respiratory syncytial virus infection of human dendritic cells and activation of replication by exogenous nitric oxide Source: Eur Respir J 2007; 30: Suppl. 51, 211s Year: 2007